We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / Products & Services / Pharmaceuticals / CMO for HPAPIs and cytotoxics / When to apply Design of Experiments (DoE) to ADC development
When to apply Design of Experiments (DoE) to ADC development
Pharmaceuticals

When to apply Design of Experiments (DoE) to ADC development

 Novasep banner When to apply Design of Experiments to ADC development

Webinar recording

Duration: 56 minutes

Abstract 

Design of experiment is a specific application of statistical techniques to enable rapid and robust development. This technique can be directed towards factor screening or process robustness depending on the specific needs of the project phase. These experiments result in a stronger process understanding, while requiring less time and fewer material resources.

Our team at Novasep has spent the last 25 years practicing this technique in complex high potent synthesis reactions, often from natural or nature-similar origin, and leveraging our expertise in chromatographic separations. With our expansion into ADC conjugation space, we have brought our breadth of experience into ADC conjugation development.

In this webinar, we will speak about the application of DoE in the ADC development process. We will identify when this tool is effective through different case studies:

  • Example of a DoE applied to analytical method development
  • When DoE is not an applicable tool and what can be implemented in its place
  • Highlights from a project where a 2-block response surface DoE increased process robustness

Why you should attend this webinar?

In this webinar, you will learn more about DoE:

  • How it is specifically applied to ADC development and how it can achieve faster development and increased robustness?
  • When are DoE tools recommended and how to apply them?
  • When are they not recommended?

Speaker

Justin Sweeley photo

Justin Sweeley is Novasep's Senior Technology Manager for Biologics in North America. He has a Bachelor degrees in Molecular Biology, Chemistry, and Biochemistry from the University of Colorado at Boulder and also completed a PhD in Chemical and Biological Engineering from Colorado State University. Justin joined Novasep in 2018. He has 9 years of experience with process development in the pharmaceutical industry and prior to joining Novasep was a senior scientist working on cGMP technology transfer for ADC projects.

It's time to know if DoE can be applied to your ADC project: attend now and learn how!

To watch this webinar recording, just fill the form below and access the online presentation:

Downloads
  • Case study: ADC payload, successful process development and manufacturing
    Case study: ADC payload, successful process development and manufacturing
    Novasep was approached by a top 10 pharmaceutical company looking for a reliable partner to manufact...
    Download +
  • Case study: Advanced Antibody Drug Conjugate characterization
    Case study: Advanced Antibody Drug Conjugate characterization
    Discover the internal platform method for fast ADC characterization, developed by Novasep's QC exper...
    Download +
  • Case study: Successful cGMP conjugation of a Novel ADC for phase I clinical trials
    Case study: Successful cGMP conjugation of a Novel ADC for phase I clinical trials
    Novasep was approached by a top 10 pharmaceutical company to help with the manufacture of a cGMP ant...
    Download +
  • A full range of CDMO services for ADCs
    A full range of CDMO services for ADCs
    Find out the solution adapted to your needs with Novasep's fully integrated CDMO services for ADCs
    Download +
Contact
You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!
.